AstraZeneca-How Much Upside is Left in Astrazeneca (AZN)? Wall Street Analysts Think 27.89%

Astrazeneca (AZN) closed the last trading session at $67.30, gaining 3.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 86.07 indicates a 27.9% upside potential.The mean estimate comprises 10 short-term price targets with a standard deviation of $10.38. While the lowest estimate of$ 67 indicates a 0.5% decline from the current price level, the most optimistic analyst expects the ...